Given the potent anti-cancer effects and mild toxicities seen in a large body of in vitro and pre-clinical studies, JQ1 may offer considerable promise in the treatment of PTEN-positive endometrial cancer, among others [12, 24, 32]. Here, PTEN is linked to endometrial cancer.